NCT00290641View on ClinicalTrials.gov

Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaMyelodysplastic Syndromes
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

graft-versus-tumor induction therapy

DRUG

cyclophosphamide

DRUG

cyclosporine

DRUG

fludarabine phosphate

DRUG

mycophenolate mofetil

PROCEDURE

umbilical cord blood transplantation

RADIATION

radiation therapy

Trial Locations (1)

55455

University of Minnesota Cancer Center, Minneapolis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Masonic Cancer Center, University of Minnesota

OTHER

NCT00290641 - Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter